CN101698146B - Microscale reactor for synthesizing radioactive drug and application thereof - Google Patents
Microscale reactor for synthesizing radioactive drug and application thereof Download PDFInfo
- Publication number
- CN101698146B CN101698146B CN2009101963458A CN200910196345A CN101698146B CN 101698146 B CN101698146 B CN 101698146B CN 2009101963458 A CN2009101963458 A CN 2009101963458A CN 200910196345 A CN200910196345 A CN 200910196345A CN 101698146 B CN101698146 B CN 101698146B
- Authority
- CN
- China
- Prior art keywords
- channel layer
- fluid
- microchannel
- reaction
- control channel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229940079593 drug Drugs 0.000 title abstract description 16
- 239000003814 drug Substances 0.000 title abstract description 16
- 230000002194 synthesizing effect Effects 0.000 title abstract description 10
- 230000002285 radioactive effect Effects 0.000 title description 3
- 238000006243 chemical reaction Methods 0.000 claims abstract description 70
- 239000012530 fluid Substances 0.000 claims abstract description 56
- 238000001179 sorption measurement Methods 0.000 claims abstract description 43
- 238000003786 synthesis reaction Methods 0.000 claims abstract description 24
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 19
- 238000007789 sealing Methods 0.000 claims abstract description 19
- 239000012217 radiopharmaceutical Substances 0.000 claims abstract description 15
- 229940121896 radiopharmaceutical Drugs 0.000 claims abstract description 15
- 230000002799 radiopharmaceutical effect Effects 0.000 claims abstract description 15
- 238000005516 engineering process Methods 0.000 claims abstract description 9
- 239000007789 gas Substances 0.000 claims description 52
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 24
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 21
- 239000011521 glass Substances 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 13
- 238000005530 etching Methods 0.000 claims description 12
- 238000010438 heat treatment Methods 0.000 claims description 11
- 230000008569 process Effects 0.000 claims description 9
- 239000002184 metal Substances 0.000 claims description 8
- 238000001704 evaporation Methods 0.000 claims description 7
- 230000008020 evaporation Effects 0.000 claims description 7
- 238000007639 printing Methods 0.000 claims description 7
- 238000007650 screen-printing Methods 0.000 claims description 4
- 238000010828 elution Methods 0.000 claims description 3
- 239000005357 flat glass Substances 0.000 claims description 3
- 238000004381 surface treatment Methods 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims 1
- 238000004891 communication Methods 0.000 claims 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims 1
- 230000003301 hydrolyzing effect Effects 0.000 claims 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 claims 1
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 claims 1
- 229920000260 silastic Polymers 0.000 claims 1
- 238000000926 separation method Methods 0.000 abstract description 18
- 238000002360 preparation method Methods 0.000 abstract description 5
- 230000001681 protective effect Effects 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 24
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 19
- 229910001220 stainless steel Inorganic materials 0.000 description 14
- 239000010935 stainless steel Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 238000010586 diagram Methods 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 150000002500 ions Chemical class 0.000 description 9
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 239000003292 glue Substances 0.000 description 7
- 238000004809 thin layer chromatography Methods 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 6
- 238000005266 casting Methods 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 239000002699 waste material Substances 0.000 description 6
- -1 Polydimethylsiloxane Polymers 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 239000002243 precursor Substances 0.000 description 5
- 238000002955 isolation Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 235000015320 potassium carbonate Nutrition 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920001971 elastomer Polymers 0.000 description 3
- 238000003682 fluorination reaction Methods 0.000 description 3
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 3
- 239000004810 polytetrafluoroethylene Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- KDLLNMRYZGUVMA-ZXXIGWHRSA-N (8r,9s,13s,14s,16r,17r)-16-fluoro-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](F)C4)O)[C@@H]4[C@@H]3CCC2=C1 KDLLNMRYZGUVMA-ZXXIGWHRSA-N 0.000 description 2
- AOYNUTHNTBLRMT-SLPGGIOYSA-N 2-deoxy-2-fluoro-aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](F)C=O AOYNUTHNTBLRMT-SLPGGIOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000003957 anion exchange resin Substances 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- QEWYKACRFQMRMB-UHFFFAOYSA-N fluoroacetic acid Chemical compound OC(=O)CF QEWYKACRFQMRMB-UHFFFAOYSA-N 0.000 description 2
- 238000002032 lab-on-a-chip Methods 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 238000000206 photolithography Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- CRTXURPUJHWBSC-JRRIWNQQSA-N (2R,3R,4R,5R)-2,3-difluoro-2,3,4,5,6-pentahydroxyhexanoyl fluoride Chemical compound F[C@]([C@@](C(=O)F)(O)F)(O)[C@H](O)[C@H](O)CO CRTXURPUJHWBSC-JRRIWNQQSA-N 0.000 description 1
- UXCAQJAQSWSNPQ-ZIVQXEJRSA-N 1-[(2r,4s,5r)-4-fluoranyl-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H]([18F])C1 UXCAQJAQSWSNPQ-ZIVQXEJRSA-N 0.000 description 1
- ZQXCQTAELHSNAT-UHFFFAOYSA-N 1-chloro-3-nitro-5-(trifluoromethyl)benzene Chemical compound [O-][N+](=O)C1=CC(Cl)=CC(C(F)(F)F)=C1 ZQXCQTAELHSNAT-UHFFFAOYSA-N 0.000 description 1
- HIIJZYSUEJYLMX-JZRMKITLSA-N 1-fluoranyl-3-(2-nitroimidazol-1-yl)propan-2-ol Chemical compound [18F]CC(O)CN1C=CN=C1[N+]([O-])=O HIIJZYSUEJYLMX-JZRMKITLSA-N 0.000 description 1
- HIIJZYSUEJYLMX-UHFFFAOYSA-N 1-fluoro-3-(2-nitroimidazol-1-yl)propan-2-ol Chemical compound FCC(O)CN1C=CN=C1[N+]([O-])=O HIIJZYSUEJYLMX-UHFFFAOYSA-N 0.000 description 1
- QEWYKACRFQMRMB-KTXUZGJCSA-N 2-fluoranylacetic acid Chemical compound OC(=O)C[18F] QEWYKACRFQMRMB-KTXUZGJCSA-N 0.000 description 1
- XIDVXDKBUJEBSC-UHFFFAOYSA-N 5-fluoro-2-nitro-1h-imidazole Chemical compound [O-][N+](=O)C1=NC=C(F)N1 XIDVXDKBUJEBSC-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- HXYZJCJSGLYQEL-FNNOIMFVSA-N FC[C@@]12C(CC[C@H]1[C@@H]1CCC3=C([C@H]1CC2)C=CC(=C3)O)O Chemical compound FC[C@@]12C(CC[C@H]1[C@@H]1CCC3=C([C@H]1CC2)C=CC(=C3)O)O HXYZJCJSGLYQEL-FNNOIMFVSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- IPPXDWMUNMTEGD-UHFFFAOYSA-N [N+](=O)([O-])C=1NC=CN1.[F] Chemical compound [N+](=O)([O-])C=1NC=CN1.[F] IPPXDWMUNMTEGD-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000001458 anti-acid effect Effects 0.000 description 1
- 230000003471 anti-radiation Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011960 computer-aided design Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052593 corundum Inorganic materials 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 238000005485 electric heating Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229920006335 epoxy glue Polymers 0.000 description 1
- 239000011094 fiberboard Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 230000008570 general process Effects 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 239000012857 radioactive material Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229910001845 yogo sapphire Inorganic materials 0.000 description 1
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/141—Feedstock
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Abstract
本发明涉及微量反应器技术,特别是一种用于合成放射性药物的微量反应器,由流体通道层、中间层、控制通道层封接成一体的封接体,以及可拆卸地插接于所述封接体的反应瓶、分离柱、吸附柱组成。其流体通道层包含可流体连通于各反应瓶、分离柱和吸附柱的流体微通道,控制通道层包含控制气体微通道和对应流体微通道的气室,由气室和中间层组成微阀控制流体微通道启闭。应用本发明的微流控芯片可以实现微量体积的常用正电子核素药物的合成。本发明制备工艺方法简便易行,无需昂贵的设备,能减少放射性药物制备之防护设备的空间和资金投入,同时可减少实验人员的工作量。
The invention relates to microreactor technology, in particular to a microreactor for synthesizing radiopharmaceuticals, a sealing body which is sealed together by a fluid channel layer, an intermediate layer and a control channel layer, and detachably inserted into the It consists of a reaction bottle, a separation column and an adsorption column of the sealed body. Its fluid channel layer includes fluid microchannels that can be fluidly connected to each reaction bottle, separation column and adsorption column. The control channel layer includes gas chambers that control gas microchannels and corresponding fluid microchannels. The microvalve control is composed of air chambers and intermediate layers. Fluidic microchannels open and close. The application of the microfluidic chip of the present invention can realize the synthesis of commonly used positron nuclide drugs in a small volume. The preparation method of the present invention is simple and easy, does not need expensive equipment, can reduce the space and capital investment of protective equipment for radiopharmaceutical preparation, and can reduce the workload of experimenters at the same time.
Description
技术领域technical field
本发明涉及微量反应器技术,特别是适合用于合成正电子核素放射性药物的微流控反应器及这种微流控反应器的应用。The invention relates to micro-reactor technology, in particular to a micro-fluidic reactor suitable for synthesizing positron nuclide radiopharmaceuticals and the application of the micro-fluidic reactor.
背景技术Background technique
微流控芯片(Micro-fluidic Chip)或称芯片实验室(Lab on a chip)是基于微电子机械系统技术基础上发展的新型技术,近年来备受人们关注,由于所需样本的化学量极少,其技术已经广泛应用于疾病诊断,药物筛选和环境检测等诸多分析领域。现有技术制作微流诊断芯片材料主要有PDMS(聚二甲基硅氧烷,Polydimethylsiloxane)等高分子材料,其具有加工成型方便、价格便宜,可以廉价的大批量生产。Micro-fluidic Chip (Micro-fluidic Chip) or lab on a chip (Lab on a chip) is a new technology developed on the basis of micro-electro-mechanical system technology. It has attracted people's attention in recent years. Its technology has been widely used in many analytical fields such as disease diagnosis, drug screening and environmental detection. In the prior art, materials for making microfluidic diagnostic chips mainly include polymer materials such as PDMS (Polydimethylsiloxane, Polydimethylsiloxane), which have the advantages of convenient processing and molding, low price, and can be mass-produced cheaply.
放射性药物,特别是正电子核素药物的合成,由于其所需的合成前体或原料化学量很少,非常适宜应用上述技术,为微流控芯片技术的应用发展提zhhj@fudan.edu.cn供了广阔的空间。The synthesis of radiopharmaceuticals, especially positron nuclide drugs, is very suitable for the application of the above-mentioned technologies due to the small amount of synthetic precursors or raw materials required, which provides a basis for the application and development of microfluidic chip technology zhhj@fudan.edu.cn Provides a wide space.
普通微流控芯片的制作一般工艺为:计算机辅助设计CAD图形——制作成掩模——玻璃片/硅片匀胶——光刻机曝光——显影后坚模——湿法蚀刻——去胶——微流控阴模——PDMS浇注预件——打孔——表面处理——芯片组装;此制作工艺需要的设备多为价格昂贵,如光刻机,真空等离子体发生器,匀胶机等。其缺点是工艺较为复杂,需要专用的设备。The general process of making an ordinary microfluidic chip is: computer-aided design CAD graphics—making a mask—glass sheet/silicon sheet uniform glue—photolithography machine exposure—mold hardening after development—wet etching—— Deglue - microfluidic negative mold - PDMS casting preform - punching - surface treatment - chip assembly; most of the equipment required for this production process is expensive, such as photolithography machines, vacuum plasma generators, Glue machine, etc. The disadvantage is that the process is more complicated and requires special equipment.
目前国内市场放射性合成装备,比如:北京派特生物技术公司的正电子药物多功能合成模块,一般体积为1000×800×600mm(长×宽×高),需要配备相应大小的防辐射铅屏蔽箱(热室)。热室通常由厚10-20mm铅为主要材料制作,设备体积大,重量沉,价格高,占据了巨大的资金和场地资源。另外,工艺说明:现行的微流控反应芯片的反应室多为采用PDMS一致的材质,通过母版浇铸制成,由于PDMS的材质的限定,吸附放射性较多,对放射性元素药物的制备有一定的抑制影响。At present, the radiosynthesis equipment in the domestic market, such as: the multifunctional synthesis module of positron drugs of Beijing Paite Biotechnology Co., Ltd., generally has a volume of 1000×800×600mm (length×width×height), and it needs to be equipped with a radiation-proof lead shielding box of the corresponding size. (hot chamber). The hot cell is usually made of 10-20mm thick lead as the main material. The equipment is bulky, heavy, and expensive, occupying huge capital and site resources. In addition, process description: the reaction chamber of the current microfluidic reaction chip is mostly made of the same material as PDMS, which is made by master casting. Due to the limitation of the material of PDMS, it absorbs more radioactivity, which has certain influence on the preparation of radioactive element drugs. inhibitory effect.
另一方面,正电子核素药物合成的前体(化学反应关键原料)通常非常昂贵,一般为1万元/克以上,有的甚至高达170万元/克(比如18氟代雌二醇18FES标记合成前体)。这些成为正电子核素药物价格高的部分原因。现行国内的放射性标记合成设备反应体积大,所需合成试剂多,使得正电子核素药物合成的成本难以下降。On the other hand, the precursors (key raw materials for chemical reactions) synthesized by positron nuclide drugs are usually very expensive, generally more than 10,000 yuan/gram, and some even as high as 1.7 million yuan/gram (such as 18 fluoroestradiol 18FES labeled synthetic precursors). These contribute in part to the high price of positronuclides. The current domestic radioactive labeling synthesis equipment has a large reaction volume and requires many synthesis reagents, which makes it difficult to reduce the cost of positron nuclide drug synthesis.
综上所述,确实有必要发展一种新的正电子核素药物合成技术来改进工艺,降低成本,使正电子核素药物在实验室内合成制备成为可能。In summary, it is indeed necessary to develop a new positronium drug synthesis technology to improve the process, reduce costs, and make it possible to synthesize positronium drugs in the laboratory.
发明内容Contents of the invention
本发明的目的是为了克服现有技术存在的不足,提供一种用于合成放射性药物的微量反应器,尤其是一种适用于合成正电子核素放射性药物的改进的微量反应器设备。该微量反应器设备是以PDMS材料制作封接板与可拆卸地插接于封接板的反应瓶、吸附柱、分离柱等组合而成,其中的PDMS封接板中包括有微阀,微通道等功能部件,将反应瓶、吸附柱、分离柱等通过这些管道和阀门相连通,共同实现化学合成和分离的功能。The object of the present invention is to overcome the deficiencies in the prior art and provide a microreactor for synthesizing radiopharmaceuticals, especially an improved microreactor device suitable for synthesizing positron nuclide radiopharmaceuticals. The microreactor equipment is composed of a sealing plate made of PDMS material and a reaction bottle, an adsorption column, a separation column, etc. that are detachably plugged into the sealing plate. Channels and other functional components connect reaction bottles, adsorption columns, separation columns, etc. through these pipes and valves to jointly realize the functions of chemical synthesis and separation.
为了实现上述目的,本发明所提供的合成正电子核素放射性药物的微量反应器包括一由流体通道层、中间层、控制通道层组合封接而成一体的封接体,以及可拆卸地插接于所述封接体的流体通道层的反应瓶、分离柱、吸附柱组合而成,其中该流体通道层包含流体微通道,可流体连通连接于各个反应瓶、分离柱和吸附柱,该控制通道层包含控制气体微通道和对应流体微通道的气室,由所述对应流体微通道的气室、中间层组成微阀,由该微阀控制对应流体微通道的启闭。其中,所述流体通道层和控制通道层的通过下述流程制作:以丝网印刷工艺在平板玻璃上印制通道层面的油墨图形;利用蚀刻液对印有油墨图案的玻璃平板表面进行蚀刻,然后洗去油墨完成阴模的制作;以玻璃阴模为母版制作阳模;在阳模为基版制作由PDMS硅橡胶材料浇注的流体通道层和控制通道层;以及将流体通道层、中间层和控制通道层的封接面对齐定位并采用空气低温等离子表面处理进行封接。In order to achieve the above object, the microreactor for synthesizing positron nuclide radiopharmaceuticals provided by the present invention includes a sealing body which is combined and sealed by a fluid channel layer, an intermediate layer and a control channel layer, and a detachable insert A combination of reaction flasks, separation columns, and adsorption columns connected to the fluid channel layer of the sealing body, wherein the fluid channel layer includes fluid microchannels, which can be fluidly connected to each reaction bottle, separation column, and adsorption column. The control channel layer includes control gas microchannels and air chambers corresponding to fluid microchannels. The air chambers and intermediate layers of the corresponding fluid microchannels form a microvalve, which controls the opening and closing of the corresponding fluid microchannels. Wherein, the fluid channel layer and the control channel layer are manufactured through the following processes: printing the ink pattern on the channel layer on the flat glass by a screen printing process; using an etching solution to etch the surface of the glass plate printed with the ink pattern, Then wash off the ink to complete the making of the female mold; use the glass female mold as the master to make the male mold; make the fluid channel layer and the control channel layer poured by PDMS silicone rubber material on the male mold as the base plate; and the fluid channel layer, the middle The sealing surfaces of the control channel layer and the control channel layer are aligned and sealed by air low-temperature plasma surface treatment.
本发明上述技术方案的优势在于:工艺方法简便易行,无需昂贵的设备,在一般实验室都可以实现。且由于该新型合成反应器的空间大小只有40×30×15mm,只需要体积较小的屏蔽箱就可以防辐射屏蔽,本发明中,只需采用250×250×200mm的铅盒就可以屏蔽,极大的减少放射性药物制备之防护设备的空间和资金投入。The advantages of the above-mentioned technical solution of the present invention are: the process method is simple and easy to implement, does not require expensive equipment, and can be realized in general laboratories. And because the space size of this novel synthesis reactor is only 40 * 30 * 15mm, only need the shielding box with smaller volume just can anti-radiation shielding, in the present invention, only need to adopt the lead box of 250 * 250 * 200mm to shield, Greatly reduce the space and capital investment of protective equipment for radiopharmaceutical preparation.
本发明的又一个方面提供了一种微量反应器,其中反应瓶包括由玻璃材质制成的反应管,连通流体通道的毛细管,以及围绕在反应管外壁的金属毛细管组成;所述金属毛细管的两端接直流电源,且所述金属毛细管的入口和出口连通高压气体供应源。当金属毛细管通电时,即对反应管进行加热;而断电后,通过金属毛细管通入高压气体时,即可对反应管进行冷却。由于利用了玻璃反应管,有利地降低了对放射性材料的吸附。更有利的是,所述反应瓶的外壁还设有温度传感器,可用于测量反应管的温度,实行温度控制。Yet another aspect of the present invention provides a microreactor, wherein the reaction bottle includes a reaction tube made of glass, a capillary communicating with a fluid channel, and a metal capillary surrounding the outer wall of the reaction tube; two of the metal capillary The terminal is connected to a DC power supply, and the inlet and outlet of the metal capillary are connected to a high-pressure gas supply source. When the metal capillary is energized, the reaction tube is heated; when the power is cut off, the reaction tube is cooled when the high-pressure gas is passed through the metal capillary. Adsorption of radioactive materials is advantageously reduced due to the use of glass reaction tubes. More advantageously, the outer wall of the reaction bottle is also provided with a temperature sensor, which can be used to measure the temperature of the reaction tube and implement temperature control.
本发明另一方面是提供了一种采用立体组装形式的微流控芯片,将反应管,吸附柱,分离柱等可拆卸地插接于封接体的流体通道层,使各个部件与流体微管道和微阀相连,共同实现化学合成和分离的功能。通过这个方法可以做到便于更换化学分离柱和反应瓶进行单独清洗。即实现各个可拆卸部件的即插即拔功能,确保了化学合成的多功能性、稳定性,同时可减少实验人员的工作量。Another aspect of the present invention is to provide a microfluidic chip in the form of three-dimensional assembly, in which reaction tubes, adsorption columns, separation columns, etc. Pipelines are connected with microvalves to jointly realize the functions of chemical synthesis and separation. Through this method, it is convenient to replace the chemical separation column and the reaction bottle for separate cleaning. That is, the plug-and-pull function of each detachable part is realized, which ensures the versatility and stability of chemical synthesis and reduces the workload of experimenters.
本发明中,应用微流控芯片合成正电子核素药物以及其它放射性药物的标记,可以实现微量体积的常用的正电子核素药物合成,包括:18氟代脱氧葡萄糖,(18F-FDG)、18氟代乙酸盐(18F-FAC)、18氟代硝基咪唑(18FMISO)、18氟代雌二醇(18FES)、18氟代脱氧胸腺嘧啶核苷(18F-FLT),以及其它放射性药物标记等。In the present invention, microfluidic chips are used to synthesize positron nuclide drugs and other radiopharmaceutical labels, which can realize the synthesis of commonly used positron nuclide drugs in a small volume, including: 18 fluorodeoxyglucose, ( 18 F-FDG) , 18 fluoroacetate ( 18 F-FAC), 18 fluoronitroimidazole ( 18 FMISO), 18 fluoroestradiol ( 18 FES), 18 fluorodeoxythymidine ( 18 F-FLT) , and other radiopharmaceutical labels.
本发明的另一个目的是利用微量反应器实现合成正电子核素放射性药物的应用,至少包括以下步骤:Another object of the present invention is to utilize microreactor to realize the application of synthesizing positron nuclide radiopharmaceutical, at least comprise the following steps:
-吸附步骤:利用压缩气体推动18F-H2O通过指定微管道经过吸附柱,使18F离子留于吸附柱;- Adsorption step: Use compressed gas to push 18F-H2O through the designated micro-pipe through the adsorption column, so that 18F ions remain in the adsorption column;
-洗脱步骤:利用压缩气体推动一种溶液通过指定的微管道经过吸附柱,洗脱吸附柱上的18F,然后通过另一指定微管道到达反应瓶,并在反应瓶内经加热蒸发而后冷却;-Eluting step: use compressed gas to push a solution through the designated micro-pipe through the adsorption column, elute the 18F on the adsorption column, then pass through another designated micro-pipe to reach the reaction bottle, and then cool down after being heated and evaporated in the reaction bottle;
-合成步骤:利用压缩气体分别推动其它反应溶液通过指定的微管道到达反应瓶,经加热蒸发后冷却;-Synthesis step: Use compressed gas to push other reaction solutions through designated micro-pipes to reach the reaction bottle, and cool after heating and evaporation;
-水解步骤:利用压缩气体推动另一溶液通过指定微管道到达反应瓶进行水解;以及- Hydrolysis step: using compressed gas to push another solution through the designated micro-channel to the reaction bottle for hydrolysis; and
-分离步骤:利用压缩气体推动反应瓶中的液体通过指定微管道经过分离柱到达收集瓶。- Separation step: Use compressed gas to push the liquid in the reaction bottle through the designated micro-channel through the separation column to the collection bottle.
上述技术方案的优势在于,由于所利用的微量反应器的反应体积很小,所需要的反应前体剂量很小,只要10-20ul,极大地减少了前体试剂的消耗,只为原先的1%,显著节约了药物制备的成本。The advantage of the above technical solution is that, due to the small reaction volume of the microreactor used, the required reaction precursor dose is very small, as long as 10-20ul, which greatly reduces the consumption of precursor reagents, only 1 %, significantly saving the cost of drug preparation.
附图说明Description of drawings
图1为根据本发明的实施例的微量反应器的流体通道层平面分布示意图,其中圆点表示为试剂管道连接口,直线表示流体通道;Fig. 1 is a schematic diagram of the plane distribution of the fluid channel layer of the microreactor according to an embodiment of the present invention, wherein the dots represent the reagent pipeline connection ports, and the straight lines represent the fluid channels;
图2为根据本发明的实施例的微量反应器的控制通道层平面分布示意图,其中圆点表示为控制通道连接口,矩形点表示气室,直线表示气体控制通道;Fig. 2 is a schematic diagram of the plane distribution of the control channel layer of the microreactor according to an embodiment of the present invention, wherein the dots represent the control channel connection ports, the rectangular points represent the gas chambers, and the straight lines represent the gas control channels;
图3为图1的流体管道层和图2的控制管道层组合后的平面分布示意图;Fig. 3 is a schematic diagram of plane distribution after the combination of the fluid pipeline layer of Fig. 1 and the control pipeline layer of Fig. 2;
图4为根据本发明的微流控芯片的PDMS层模具制作过程的示意图;4 is a schematic diagram of the PDMS layer mold manufacturing process of the microfluidic chip according to the present invention;
图5为根据本发明的微流控反应芯片的微阀门原理的剖面示意图;5 is a schematic cross-sectional view of the microvalve principle of the microfluidic reaction chip according to the present invention;
图6为根据本发明的玻璃反应管的结构原理示意图;6 is a schematic diagram of the structural principle of the glass reaction tube according to the present invention;
图7为根据本发明的微流控芯片的组装示意图;7 is a schematic diagram of the assembly of the microfluidic chip according to the present invention;
图8为根据本发明的微流控芯片的平面示意图,显示吸附柱所在位置;8 is a schematic plan view of the microfluidic chip according to the present invention, showing the position of the adsorption column;
图9为根据本发明的一个实施例合成18FDG时应用微流控芯片的示意图;Fig. 9 is a schematic diagram of applying a microfluidic chip when synthesizing 18FDG according to an embodiment of the present invention;
图10为三氟甘露糖与18F离子氟化反应后的混合液TLC的分析图;Fig. 10 is the analysis diagram of the mixed solution TLC after the fluorination reaction between mannose trifluoride and 18F ion;
图11为18FDG产品的TLC分析图,其中流动相乙腈/水(95/5=v/v),Rf=0.45-0.65,放化纯度>96%;Figure 11 is a TLC analysis chart of 18FDG product, wherein mobile phase acetonitrile/water (95/5=v/v), Rf=0.45-0.65, radiochemical purity>96%;
图12为根据本发明的一个实施例合成18FAC时应用微流控芯片的示意图;Fig. 12 is a schematic diagram of applying a microfluidic chip when synthesizing 18FAC according to an embodiment of the present invention;
图13为18FAC产品的TLC分析图,其中Rf=0.16,流动相乙腈/水(95/5,V/V),放化纯度大于95%;以及Fig. 13 is the TLC analysis figure of 18FAC product, wherein Rf=0.16, mobile phase acetonitrile/water (95/5, V/V), radiochemical purity is greater than 95%; And
图14为8FAC产品另一个TLC分析图,其中Rf=0.8-0.9,流动相甲醇,放化纯度98.4%,原点为游离18F离子。Figure 14 is another TLC analysis chart of 8FAC product, wherein Rf=0.8-0.9, mobile phase methanol, radiochemical purity 98.4%, and the origin is free 18F ion.
具体实施方式Detailed ways
本发明所提供的用于合成正电子核素药物的微量反应器,亦称微流控芯片主要包括一由流体通道层、控制通道层和中间层组成的封接体,以及反应瓶、分离器、和吸附柱等元件组成。其中该封接体采用聚二甲基硅氧烷(PDMS)为材料浇注并封接而成,主要包含设在流体通道层中连接各个反应瓶、分离器及吸附柱的流体微通道,设在控制通道层中的气体控制微通道,以及控制微流体通道启闭的微阀等功能部件。The microreactor for synthesizing positron nuclide drugs provided by the present invention, also known as microfluidic chip, mainly includes a sealing body composed of a fluid channel layer, a control channel layer and an intermediate layer, as well as a reaction bottle and a separator , and adsorption columns and other components. Among them, the sealing body is made of polydimethylsiloxane (PDMS) by casting and sealing, and mainly includes fluid microchannels connected to each reaction bottle, separator and adsorption column in the fluid channel layer, and is located in the fluid channel layer. Control the gas in the channel layer to control the microchannel, and control the opening and closing of the microfluidic channel and other functional parts such as the microvalve.
图1所示为根据发明的微流控芯片中的封接体中的流体通道层的平面分布示意图,其中圆点表示为试剂管道的连接口,圆点之间的直线表示为流体通道。图2为微流控芯片封接体中的控制通道层的平面分布示意图,其中圆点表示控制管道的连接口,矩形点表示控制管道的气室,即微阀,圆点和矩形点之间为控制气体管道。图3为图1的流体管道层和图2的控制管道层组合后的平面分布示意图。Fig. 1 is a schematic diagram showing the plane distribution of the fluid channel layer in the sealing body of the microfluidic chip according to the invention, wherein the dots represent the connection ports of the reagent pipelines, and the straight lines between the dots represent the fluid channels. Figure 2 is a schematic diagram of the planar distribution of the control channel layer in the sealing body of the microfluidic chip, where the dots indicate the connection port of the control pipeline, and the rectangular dots indicate the air chamber of the control pipeline, that is, the microvalve, between the dots and the rectangular dots For the control gas pipeline. Fig. 3 is a schematic plan view of the combination of the fluid pipeline layer in Fig. 1 and the control pipeline layer in Fig. 2 .
该微流控芯片的封接体即微通道的具体制作主要包括四部分:流体通道层和控制通道层的模具制作、阴阳模具的翻模,硅橡胶的浇注成型,以及浇注体的封接装配。The specific production of the sealing body of the microfluidic chip, that is, the microchannel, mainly includes four parts: the mold making of the fluid channel layer and the control channel layer, the turning of the male and female molds, the casting of silicone rubber, and the sealing and assembly of the casting body .
1)模具的制作:1) Mold making:
流体通道层面和控制通道层面的图形,分别如图1和图2所示,可以分别用AutoCAD软件绘制。图3所示为图1的流体通道层与图2的控制通道层组合后的平面分布示意图。图形区域为26×30mm,线宽0.2-0.3mm,气体和液体通道入口为1mm。通过油墨丝网印刷的工艺将上述流体通道层和控制通道层分别制作成丝网版,本发明优选250目油性聚酯网版,参见图4。然后将抗强酸蚀刻油墨,通过丝印方法印在预先洗净烘干的玻璃表面,再将印有油墨图案的玻璃放入玻璃蚀刻液,例如含氢氟酸50ml,浓硫酸20ml,水50ml的蚀刻液中进行蚀刻,玻璃刻蚀的深度与以下因素有关:蚀刻液的浓度、溶液的温度、蚀刻的时间。一般为5min/30℃。具体根据当时实际情况而定,一般在室温下,蚀刻时间为4-5分钟。刻蚀后的玻璃用5%的NaOH水溶液除去油墨。从而完成阴模模具的制作。所述的丝网版的制作过程如下:CAD图案——菲林输出或硫酸纸打印图案——晒图机晒图〔丝网上感光胶〕——水冲显影——热风吹干。The graphics of the fluid channel level and the control channel level are shown in Figure 1 and Figure 2 respectively, which can be drawn with AutoCAD software. FIG. 3 is a schematic plan view showing the combination of the fluid channel layer in FIG. 1 and the control channel layer in FIG. 2 . The graphic area is 26×30mm, the line width is 0.2-0.3mm, and the gas and liquid channel inlet is 1mm. The above-mentioned fluid channel layer and control channel layer are respectively made into screen plates by the process of ink screen printing, and a 250-mesh oily polyester screen plate is preferred in the present invention, see FIG. 4 . Then print the anti-acid etching ink on the pre-cleaned and dried glass surface by silk screen printing, and then put the glass printed with the ink pattern into the glass etching solution, such as etching containing 50ml of hydrofluoric acid, 20ml of concentrated sulfuric acid, and 50ml of water Etching is carried out in the liquid, and the depth of glass etching is related to the following factors: the concentration of the etching liquid, the temperature of the solution, and the etching time. Generally 5min/30℃. It depends on the actual situation at that time, generally at room temperature, the etching time is 4-5 minutes. The etched glass was deinked with 5% NaOH aqueous solution. Thereby completing the making of female mold. The production process of the screen plate is as follows: CAD pattern—film output or sulfuric acid paper printing pattern—printing machine printing [photosensitive glue on the screen]—water flushing development—hot air drying.
2)阴阳模具的翻模:2) Overturning of Yin and Yang molds:
以阴模为母版,用低粘度的环氧灌注胶(A/B胶)进行浇注,25°烘箱保温,等待环氧胶固化。然后将其与玻璃剥离,即为阳模。阳模包括流体通道层阳模和控制通道层阳模两种层面。Use the female mold as the master plate, pour with low-viscosity epoxy pouring glue (A/B glue), keep warm in a 25° oven, and wait for the epoxy glue to cure. Then it is peeled off from the glass, which is the positive mold. The male mold includes two levels of the fluid channel layer male mold and the control channel layer male mold.
3)PDMS的浇注:3) Pouring of PDMS:
以阳模为母版,将PDMS胶(胶体与固化剂的比例为10∶1)浇注到阳模上,厚度5mm,真空抽气除泡,然后放入80℃,2小时保温固化。等PDMS固化后,小心将PDMS于环阳模版剥离,即为PDMS浇注层。Using the male mold as the master, pour PDMS glue (the ratio of colloid to curing agent is 10:1) onto the male mold with a thickness of 5mm, vacuum pump to remove air bubbles, and then put it in 80°C for 2 hours for curing. After the PDMS is cured, carefully peel off the PDMS from the ring positive template, which is the PDMS casting layer.
4)封接组装:4) Sealing assembly:
流体通道层与控制通道层,分别打孔待用。另准备同样材质的PDMS中间层0.2mm厚,将流体通道层的封结面和中间层同时经空气等离子体处理,将两处理过的面相互贴近,两橡胶面会相互胶粘。等待二小时后,再以相同的方法将另两需胶和的面胶粘。但要注意上下位置要对准。此为三层封接体。完成之后,准备相应大小的载体玻璃片,在上面涂上约0.2-0.3mm的PDMS胶,水平放置待固化后,也经空气等离子体处理后将三层封接体粘合在玻璃载体上。至此微流控芯片的封接体制作完成。The fluid channel layer and the control channel layer are respectively punched for use. In addition, prepare a PDMS middle layer of the same material with a thickness of 0.2mm. The sealing surface of the fluid channel layer and the middle layer are treated with air plasma at the same time, and the two treated surfaces are brought close to each other, and the two rubber surfaces will be glued to each other. After waiting for two hours, glue the other two surfaces that need to be glued together in the same way. But pay attention to the alignment of the upper and lower positions. This is a three-layer seal. After completion, prepare a carrier glass sheet of the corresponding size, coat it with PDMS glue of about 0.2-0.3 mm, place it horizontally to be cured, and bond the three-layer sealing body on the glass carrier after air plasma treatment. So far, the sealing body of the microfluidic chip is completed.
微阀是微流控芯片的关键点,如图5所示,流体通道层10和控制通道20之间设有中间层30,其中流体通道的下表面设有流体通道11,在控制通道20的上表面对应该流体通道11的位置设有连通气体控制通道21的气室22,该对应流体通道11的气室22加由弹性可变形材料制成的中间隔离层30一起组成了控制流体通道11启闭的微阀。图5的上图表示为微阀开启状态,小半圆的流体通道11内气压与下方气室22的气压一致,中间隔离层30的橡胶处于松弛状态,使流体通道11保持流通。图5的下图表示为微阀封闭状态,当控制通道层20的控制通道21和气室22内充压时,中间隔离层30的橡胶弹性体变形鼓起,堵塞上方的管道11,即阀门关闭。The microvalve is a key point of the microfluidic chip. As shown in FIG. The position of the upper surface corresponding to the
下面参见图6来描述本发明另一个主要部件反应瓶(管)的制作:反应管40为直径4mm,长30mm,壁厚0.2mm的薄壁玻璃试管,呈小灯泡状,反应管外表面绕有直径为0.4-0.7mm不锈钢毛细管41,当不锈钢毛细管两端通以0.5A的直流电时,即为电加热丝。当不锈钢毛细管入口通入0.5Bar压缩气体,即为冷却管。反应瓶全部浸没在固化的PDMS材料中,此PDMS材料即当保温作用,又当支撑材料。另有两根聚四氟乙烯(PTFE)毛细管42用于与PDMS流体通道层相应的管道接口相连,在反应瓶/管40的侧壁和底部还配有测量温度实现温度控制的传感器43。Referring to Fig. 6 below, describe the making of another main component reaction bottle (tube) of the present invention:
图7为根据本发明的微流控芯片的示例的立体组装示意图,在玻璃载体1的上方是浇注体,其上层为流体通道层10,下层为控制通道层20,中间为隔离层30。于流体通道层10中设有流体通道11,于控制通道层20中设有控制通道21。反应瓶40,吸附柱50,及分离器60分别插接在流体通道层10的连接孔中,与流体通道11相连通。而控制通道20中的气体微阀22对应于相应的流体通道11的控制点位置设置,并连同气体控制通道。7 is a three-dimensional assembly diagram of an example of a microfluidic chip according to the present invention. Above the
图8为根据本发明的微流控芯片的平面示意图,显示吸附柱50所在的位置。图8所示的为18F离子吸附柱,为实现18F放射性核素的标记,需要阴离子交换树脂对18F离子进行分离。采用立体式组装法,有利于更换离子吸附柱。根据本发明的一个实施例,将阴离子吸附(分离)柱于PDMS芯片主体分离,单独制作,由内径0.6mm的PTFE管,内填15mm的阴离子交换树脂QMA填料,筛板为5um的聚丙烯纤维板。其两端与PDMS芯片主体相连。FIG. 8 is a schematic plan view of the microfluidic chip according to the present invention, showing the position of the
应用本发明的微流控芯片可以实现微量体积的常用正电子核素药物的合成,包括:18氟代脱氧葡萄糖,(18F-FDG)、18氟代乙酸盐(18F-FAC)、18氟代硝基咪唑(18FMISO)、18氟代雌二醇(18FES)、18氟代脱氧胸腺嘧啶核苷(18F-FLT),以及其它放射性药物标记等。具体的合成工艺主要包括以下步骤:1)利用压缩气体推动18F-H2O通过指定微管道经过吸附柱,使18F离子留于吸附柱;2)利用压缩气体推动一种溶液通过指定的微管道经过吸附柱,洗脱吸附柱上的18F,然后通过另一指定微管道到达反应瓶,并在反应瓶内经加热蒸发而后冷却;3)利用压缩气体分别推动其它反应溶液通过指定的微管道到达反应瓶并经加热蒸发后冷却,从而实现合成反应;4)利用压缩气体推动另一溶液通过指定微管道到达反应瓶对合成物进行水解;以及5)利用压缩气体推动反应瓶中的液体通过指定微管道经过分离柱到达收集瓶;重复以上必要的一个或多个步骤,以获得最终所要合成和分离的药物。The application of the microfluidic chip of the present invention can realize the synthesis of commonly used positron nuclide drugs in a small volume, including: 18 fluorodeoxyglucose, (18F-FDG), 18 fluoroacetate (18F-FAC), 18 fluorine Nitroimidazole (18FMISO), 18-fluoroestradiol (18FES), 18-fluoro-deoxythymidine (18F-FLT), and other radiopharmaceutical labels. The specific synthesis process mainly includes the following steps: 1) Use compressed gas to push 18F-H2O through the designated micropipe through the adsorption column, so that 18F ions remain in the adsorption column; 2) Use compressed gas to push a solution through the designated micropipe through the adsorption column column, elutes the 18F on the adsorption column, then reaches the reaction flask through another designated micropipe, and is heated and evaporated in the reaction flask and then cooled; After being heated and evaporated, it is cooled to realize the synthesis reaction; 4) using compressed gas to push another solution through the designated micro-pipe to reach the reaction bottle to hydrolyze the compound; and 5) using compressed gas to push the liquid in the reaction bottle through the designated micro-pipe to pass through The separation column reaches the collection bottle; repeat one or more steps necessary above to obtain the final drug to be synthesized and separated.
下面进一步结合实施例来说明利用本发明的微量反应器即微流控芯片来合成正电子核素药物的应用:The application of the microreactor of the present invention, that is, the microfluidic chip, to synthesize positron nuclide drugs is further described below in conjunction with the examples:
实施例1:18F-脱氧葡萄糖的标记合成(图9):Example 1: Labeled synthesis of 18F-deoxyglucose (Figure 9):
由于本发明的微流控芯片中,液体流动的动力来自气动压力,试剂加入的量为定量的,即预先将要参加反应的试剂加入相应的管道内,试剂的加入为“全或无”式,即要么全部加入,要么一点都不加,没有中间形式。液体的气压为20-40Kpa,气体控制阀门气压为60-150Kpa。Since in the microfluidic chip of the present invention, the power of liquid flow comes from pneumatic pressure, the amount of reagents added is quantitative, that is, the reagents to participate in the reaction are added to the corresponding pipelines in advance, and the addition of reagents is an "all or nothing" formula, That is, either all of them are added, or they are not added at all, and there is no intermediate form. The air pressure of the liquid is 20-40Kpa, and the air pressure of the gas control valve is 60-150Kpa.
设备准备状态时,Q1,Q2-Q13管都加气压60-90Kpa,此时所有阀门处于关闭状态。吸附柱50预先用0.5M K2CO3溶液100ul冲洗,然后用500ul的水洗到中性。液体管道分布加载相应的试剂,即Y1:500ul,18F-H2O;Y2:废液瓶;Y3:20ul,淋洗液(K222,300mg/K2CO3,55mg/0.5mlH2O/19.5ml MeCN);Y4:20ul,无水乙腈;Y5:20ul,三氟甘露糖溶液(100mg/8ml无水乙腈);Y6:20ul,1N NaOH;Y7:20ul,1N HCl;Y8:50ul,水;Y10:30KpaN氮气;Y11:废液瓶(放空);另外Y9管道出口接分离柱(30mg AG50/50mg AG11A8/30mg Al2O3(N)/15mgC18),末端与收集瓶相连。When the equipment is in the ready state, the Q1, Q2-Q13 pipes are all pressurized at 60-90Kpa, and all valves are closed at this time. The
合成过程:Synthesis:
A.吸附:开启Q1/Q2阀(所谓开启阀门就是将相应管道放空),Y1管内的18F-H2O在压缩气体的推动下经过吸附柱50,18F离子留于柱50上,流出的水到达Y2的废液瓶。关闭Q1/Q2阀A. Adsorption: Open the Q1/Q2 valve (the so-called opening the valve is to empty the corresponding pipeline), the 18F-H2O in the Y1 tube passes through the
B.洗脱和蒸发:开启Q3/Q4/Q6/Q13阀门,Y3管内的溶液在压缩气体的推动下经过吸附柱,通过阀门4,6后到达反应瓶40。不锈钢毛细管通上0.5A的直流电加热,待瓶底实际稳定为95℃时,停止加热。不锈钢毛细管通压缩气体冷却,至稳定低于60℃。关闭Q3/Q4/Q6/Q13阀门。B. Elution and evaporation: Open the Q3/Q4/Q6/Q13 valve, the solution in the Y3 tube will pass through the adsorption column under the push of the compressed gas, and then reach the
C.再蒸发:开启Q5/Q6/Q13阀门,Y4管内的液体在压缩气体的推动下,Q5,Q6经过到达反应瓶40。不锈钢毛细管通上0.5A的直流电加热,待瓶底实际稳定为100℃时,停止加热。不锈钢毛细管通压缩气体冷却,至稳定低于60℃。关闭Q5/Q6/Q13阀门。C. Evaporation again: open the Q5/Q6/Q13 valve, the liquid in the Y4 tube is driven by the compressed gas, and Q5 and Q6 pass through to reach the
D.氟化反应:开启Q7/Q13阀门,Y5内的溶液在压缩气体的推动下经过Q7阀到达反应瓶40。关闭Q7/Q13阀门,不锈钢毛细管通上0.5A的直流电加热,待瓶底实际稳定为90℃时,保持2min。再开启Q7/Q13阀门,继续加热蒸干。当温度为100℃时,停止加热。不锈钢毛细管通压缩气体冷却,至稳定低于60℃。D. Fluorination reaction: open the Q7/Q13 valve, and the solution in Y5 reaches the
E.水解:开启Q8/Q13阀门,Y6内的溶液在压缩气体的推动下经过Q8阀到达反应瓶40。关闭Q8/Q13阀门,室温保持2min。开启Q9/Q13阀门,Y7内的溶液在压缩气体的推动下经过Q9阀到达反应瓶40,反应液被中和。E. Hydrolysis: Open the Q8/Q13 valve, and the solution in Y6 reaches the
F.化学分离提纯:开启Q1/Q12/Q13阀门,Y10内的压缩气体将反应瓶40中的液体压出,通过Q11阀,由管道Y9经过分离柱(30mgAG50/50mgAG11A8/30mgAl2O3(N)/15mgC18)到达收集瓶。关闭Q1/Q12/Q13阀门。然后开启Q9/Q13阀门,Y8内的液体在压缩气体的推动下经过Q9阀到达反应瓶40。再开启Q1/Q12/Q13阀门,Y10内的压缩气体将反应瓶40中的液体压出,再次流过分离柱到达收集瓶。此为18FDG产品。F. Chemical separation and purification: open the Q1/Q12/Q13 valve, the compressed gas in the Y10 will press the liquid in the
Radio-TLC(放射性薄层色谱)分析结果显示:标记中间体的标记率为92.5%(如图10)产品放化纯度>95%(如图11)。Radio-TLC (radioactive thin-layer chromatography) analysis results showed that the labeling rate of the labeled intermediate was 92.5% (as shown in Figure 10) and the radiochemical purity of the product was >95% (as shown in Figure 11).
实施例2:18F-氟代乙酸盐(18FAC)的合成(图12)Example 2: Synthesis of 18F-fluoroacetate (18FAC) (Figure 12)
液体的气压为20-40Kpa,气体控制阀门气压为60-150Kpa。设备准备状态时,Q1,Q2-Q13管都加气压60-90Kpa,此时所有阀门处于关闭状态。吸附柱50预先用0.5M K2CO3溶液100ul冲洗,然后用500ul的水洗到中性。液体管道分布加载相应的试剂,即Y1:500ul,18F-H2O;Y2:废液瓶;Y3:20ul淋洗液(K222,300mg/K2CO3,55mg/0.5mlH2O/19.5mlMeCN);Y4:20ul无水乙腈;Y5:20ul O-乙基羟乙酸酯甲基磺酸盐EOMG(5ulEOMG/500ul无水乙腈);Y6:100ul水;Y7:40ul,1N NaOH:Y8:80ul,0.5N HCl;Y10:200ul水;Y11:废液瓶(放空);另外Y9管道出口接吸附水解柱Oasis-HLB(直径2.5×15mm)。The air pressure of the liquid is 20-40Kpa, and the air pressure of the gas control valve is 60-150Kpa. When the equipment is in the ready state, the Q1, Q2-Q13 pipes are all pressurized at 60-90Kpa, and all valves are closed at this time. The
合成过程:Synthesis:
G.吸附:开启Q1/Q2阀(所谓开启阀门就是将相应管道放空),Y1管内的18F-H2O在压缩气体的推动下经过吸附柱50,18F离子留于柱50上,流出的水到达Y2的废液瓶内。关闭Q1/Q2阀G. Adsorption: Open the Q1/Q2 valve (the so-called open valve is to empty the corresponding pipeline), the 18F-H2O in the Y1 tube passes through the
H.洗脱和蒸发:开启Q3/Q4/Q6/Q13阀门,Y3管内的溶液在压缩气体的推动下经过吸附柱,通过阀门4,6后到达反应瓶40。不锈钢毛细管通上0.5A的直流电加热,待瓶底实际稳定为95℃时,停止加热。不锈钢毛细管通压缩气体冷却,至稳定低于60℃。关闭Q3/Q4/Q6/Q13阀门。H. Elution and evaporation: open the Q3/Q4/Q6/Q13 valve, the solution in the Y3 tube passes through the adsorption column under the push of the compressed gas, and reaches the
I.再蒸发:开启Q5/Q6/Q13阀门,Y4管内的液体在压缩气体的推动下,Q5,Q6经过到达反应瓶40。不锈钢毛细管通上0.5A的直流电加热,待瓶底实际稳定为100℃时,停止加热。不锈钢毛细管通压缩气体冷却,至稳定低于60℃。关闭Q5/Q6/Q13阀门。I. Evaporation again: open the Q5/Q6/Q13 valve, the liquid in the Y4 tube is driven by the compressed gas, and Q5 and Q6 reach the
J.氟化反应:开启Q7/Q13阀门,Y5内的溶液在压缩气体的推动下经过Q7阀到达反应瓶40。关闭Q7/Q13阀门,不锈钢毛细管通上0.5A的直流电加热,待瓶底实际稳定为90℃时,保持3min。J. Fluorination reaction: open the Q7/Q13 valve, and the solution in Y5 reaches the
K.加水稀释:开启Q8/Q13/Y13阀门,Y6内的溶液在压缩气体的推动下经过Q8阀到达反应瓶40。K. Dilute with water: open the Q8/Q13/Y13 valve, and the solution in Y6 will reach the
L.HLB柱吸附:开启Q1/Q12/Q13阀门,Y10内的前端的压缩气体将反应瓶中的液体压出,同时后部的200ul的水再经过反应瓶40由Y9管经过Oasis-HLB吸附水解柱,直止排空。次流出液废弃。L. HLB column adsorption: Open the Q1/Q12/Q13 valve, the compressed gas in the front end of Y10 will press out the liquid in the reaction bottle, and at the same time, the 200ul water in the rear will pass through the
M.水解:开启Q9/Q13/Q12阀门,Y6内的溶液在压缩气体的推动下经过Q9阀到达Oasis-HLB。收集流出液。保持3min。开启Q10/Q13/12阀门,Y8内的溶液(0.5N,HCl)在压缩气体的推动下经过Q10阀到达Oasis-HLB柱,到达收集瓶。M. Hydrolysis: Open the Q9/Q13/Q12 valve, and the solution in Y6 will reach Oasis-HLB through the Q9 valve under the push of compressed gas. Collect the effluent. Keep it for 3min. Open the Q10/Q13/12 valve, and the solution (0.5N, HCl) in Y8 will pass through the Q10 valve to the Oasis-HLB column under the push of compressed gas, and then to the collection bottle.
N.将收集瓶内的溶液用NaHCO3调pH5-8.5。即为产品。N. Adjust the pH of the solution in the collection bottle to 5-8.5 with NaHCO3. That is the product.
TLC分析结果显示(图13、14),放化纯度95%。The results of TLC analysis (Fig. 13, 14) showed that the radiochemical purity was 95%.
可以理解的是上述关于本发明的技术特征、优点和有益效果的介绍仅为说明本发明原理而提供的具体实施例,并非对本发明的权利要求的限定,在不脱离本发明实质的前提下利用本发明原理所做的任何修改和变化可能仍落在本发明的权利要求保护范围内,因此本发明的要求保护的范围应由所附权利要求所定义的技术特征以及其等同特征来限定。It can be understood that the above-mentioned introduction about the technical features, advantages and beneficial effects of the present invention is only a specific embodiment provided to illustrate the principle of the present invention, and is not a limitation of the claims of the present invention, and can be used without departing from the essence of the present invention. Any modifications and changes made by the principles of the present invention may still fall within the protection scope of the claims of the present invention, so the protection scope of the present invention should be defined by the technical features defined in the appended claims and their equivalent features.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101963458A CN101698146B (en) | 2009-09-24 | 2009-09-24 | Microscale reactor for synthesizing radioactive drug and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009101963458A CN101698146B (en) | 2009-09-24 | 2009-09-24 | Microscale reactor for synthesizing radioactive drug and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101698146A CN101698146A (en) | 2010-04-28 |
| CN101698146B true CN101698146B (en) | 2011-10-26 |
Family
ID=42146611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009101963458A Expired - Fee Related CN101698146B (en) | 2009-09-24 | 2009-09-24 | Microscale reactor for synthesizing radioactive drug and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101698146B (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101851580A (en) * | 2010-05-27 | 2010-10-06 | 苏州大学 | Radioactive gas collection cell culture device |
| CN101968131B (en) * | 2010-09-21 | 2013-04-24 | 中国科学院上海微系统与信息技术研究所 | Capillary micro valve based on phase-substituted triggering and application thereof |
| CN103537239B (en) * | 2012-07-08 | 2016-01-06 | 复旦大学附属肿瘤医院 | Small size [ 18f] fluorine isotope labeling reactor and application thereof |
| CN103852518B (en) * | 2012-12-06 | 2016-05-25 | 苏州生物医学工程技术研究所 | A kind of multichannel independent dominating set of based thin film acoustic wave device becomes micro-fluidic chip |
| CN103920544B (en) * | 2014-04-14 | 2015-06-17 | 南京理工大学 | Method for preparing polydimethylsiloxane (PDMS) micro-fluidic chip |
| CN107530455A (en) * | 2015-02-10 | 2018-01-02 | Abt分子成像公司 | With automatic biological label production system associated with dosage synthesize card |
| CN105985385B (en) * | 2015-05-07 | 2018-12-21 | 陕西正泽生物技术有限公司 | A kind of integrated fluidic plate synthesis18The method of F-FDG |
| CN110560188B (en) * | 2019-09-19 | 2021-09-28 | 济南大学 | Preparation method of multi-stage sample injection micro-fluidic chip for synthesizing Ag/Ag2S/CdS heterojunction |
| CN114247488B (en) * | 2021-11-23 | 2023-12-08 | 东胜神州(北京)医学诊断技术有限公司 | Manufacturing method of bag reactor |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1117996A2 (en) * | 1998-08-28 | 2001-07-25 | Febit Ferrarius Biotechnology GmbH | Method and device for producing and/or analyzing biochemical reaction supporting materials |
| GB2366529A (en) * | 2000-09-11 | 2002-03-13 | Univ Sheffield | Fluidic control valve for an assembly containing a plurality of microreactors |
| CN1822897A (en) * | 2003-07-11 | 2006-08-23 | 日本碍子株式会社 | microreactor |
| CN101166570A (en) * | 2005-04-26 | 2008-04-23 | 阿维扎技术有限公司 | Microfluidic structure and method of manufacturing the same |
| CN101267885A (en) * | 2005-09-20 | 2008-09-17 | 皇家飞利浦电子股份有限公司 | A microfluidic regulating device |
-
2009
- 2009-09-24 CN CN2009101963458A patent/CN101698146B/en not_active Expired - Fee Related
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1117996A2 (en) * | 1998-08-28 | 2001-07-25 | Febit Ferrarius Biotechnology GmbH | Method and device for producing and/or analyzing biochemical reaction supporting materials |
| GB2366529A (en) * | 2000-09-11 | 2002-03-13 | Univ Sheffield | Fluidic control valve for an assembly containing a plurality of microreactors |
| CN1822897A (en) * | 2003-07-11 | 2006-08-23 | 日本碍子株式会社 | microreactor |
| CN101166570A (en) * | 2005-04-26 | 2008-04-23 | 阿维扎技术有限公司 | Microfluidic structure and method of manufacturing the same |
| CN101267885A (en) * | 2005-09-20 | 2008-09-17 | 皇家飞利浦电子股份有限公司 | A microfluidic regulating device |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101698146A (en) | 2010-04-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101698146B (en) | Microscale reactor for synthesizing radioactive drug and application thereof | |
| JP5344921B2 (en) | Automated integrated microfluidic device | |
| JP2006527367A5 (en) | ||
| US8110148B2 (en) | Apparatus and method using rotary flow distribution mechanisms | |
| JP2008522795A (en) | Microfluidic device with chemical reaction circuit | |
| Keng et al. | Emerging technologies for decentralized production of PET tracers | |
| US11383235B2 (en) | Device and method for microscale chemical reactions | |
| US20120180884A1 (en) | Interconnection of Microfluidic Devices | |
| CN109173951B (en) | Modular integrated synthesis device and method for PET imaging agent based on microfluidic technology | |
| CN102083525A (en) | Microfluidic radiosynthesis system for positron emission tomography biomarkers | |
| WO1995026796A1 (en) | Integrated chemical synthesizers | |
| CN113318798A (en) | Micro-column array micro-fluidic chip for lossless capture of liquid drops and preparation method and application thereof | |
| JPWO2019092989A1 (en) | Microfluidic chips and microfluidic devices | |
| CN103537239B (en) | Small size [ 18f] fluorine isotope labeling reactor and application thereof | |
| CN108404830A (en) | A kind of micro passage reaction | |
| CN102183388B (en) | Preparation method of free flow electrophoresis chip with two-dimensional depth | |
| CN105817188A (en) | Metal small channel reactor | |
| CN107223071A (en) | Monolithic body | |
| CN104350031B (en) | For the disposable module of the isotopic device of synthesizing radioactive with for the method manufacturing described module | |
| CN212120030U (en) | Is used for synthesis18Microfluidic integrated module of F-FDG | |
| Novotný et al. | Miniaturization and microfluidics | |
| CN108187767B (en) | A Programmable Modular PDMS Microfluidic Chip Mold System | |
| Salvador et al. | Integrated anion-exchange cartridge for [18F] F-preconcentration in a PDMS radiopharmacy chip | |
| CN117085753A (en) | A multi-channel mixed solution gas shear droplet generation chip and its use method | |
| CN108786677B (en) | A kind of microreactor of Click labelled synthesis PET imaging agent and its preparation and reaction method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20111026 Termination date: 20210924 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
